Announcing the 2018 Sternfels Prize Winner

Jennifer Le, PharmD
Improving narrow therapeutic drug dosing in critically ill neonatal and pediatric patients on extracorporeal life support
UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences

Each new pharmaceutical is a life-changing technological wonder. The Sternfels Prize was created to reduce the risk associated with the real-world use of pharmaceuticals. The purpose of the prize is to incentivize pharmacologists, pharmacists, medical practitioners, academics, and students to think about ways to reduce the real world risks patients face from polypharmacy, interacting co-morbidities, and genetic variations.

The prize is awarded to the most novel, important, and testable idea to reduce life threatening drug-drug, drug-disease, or pharmacogenomic interactions. All submissions must be the applicant’s own work and not already be adequately addressed on an existing drug label or in a scholarly work. The winning submission will receive $35,000 (USD). 

The Sternfels Prize is named in honor of Edith and Ernst Sternfels. Ernst was an engineer involved in the design and construction of chemical plants around the world, including many involved in the synthesis of life-improving molecules. Edith was a nurse, dedicated to the welfare and treatment of patients. Together, they represent the wingspan of modern medicine, from highly technical science to personal attention and care.

*Qualifying submissions are proposals for novel, unpublished ideas as determined by the Sternfels staff